{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:14:54Z","timestamp":1777122894607,"version":"3.51.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clindermatol.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:43:39Z","timestamp":1637318619000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nutrition and bullous diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Victoria","family":"Stoj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.10.009_bib0001","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1976.tb04368.x","article-title":"International mortality from bullous diseases since 1950","volume":"94","author":"Savin","year":"1976","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0002","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archdermatol.2009.205","article-title":"Mortality of bullous skin disorders from 1979 through 2002 in the United States","volume":"145","author":"Risser","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0003","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clindermatol.2011.03.016","article-title":"Quality of life in patients with bullous dermatoses","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0005","doi-asserted-by":"crossref","first-page":"a209","DOI":"10.1136\/bmj.a209","article-title":"Incidence of bullous pemphigoid and pemphigus vulgaris","volume":"337","author":"Joly","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0006","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3906\/sag-1602-99","article-title":"Possible triggering factors and comorbidities in newly diagnosed autoimmune bullous diseases","volume":"47","author":"Akarsu","year":"2017","journal-title":"Turkish J Med Sci"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0007","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0019-5154.159620","article-title":"Pathophysiology of autoimmune bullous diseases: nature versus nurture","volume":"62","author":"Patel","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0009","first-page":"367","article-title":"Early description of diet-induced blistering skin diseases in medieval Persia: Avicenna's point of view","volume":"14","author":"Atarzadeh","year":"2016","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0010","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jdv.15731","article-title":"Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation","volume":"33","author":"Kneiber","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0011","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2018.08.030","article-title":"Prevalence estimates for pemphigoid in the United States: a sex-adjusted and age-adjusted population analysis","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J Amer Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0012","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0013","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","article-title":"New insights into the pathogenesis of bullous pemphigoid: 2019 update","author":"Genovese","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0014","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","article-title":"Effects of vitamin D on the peripheral adaptive immune system: a review","volume":"10","author":"Peelen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-540-71029-5_12","article-title":"Induction of tolerogenci dendritic cells by vitamin D receptor agonists","volume":"188","author":"Adorini","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0016","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.4049\/jimmunol.134.5.3032","article-title":"Kermani-Arabi, et\u00a0al. 1,25-Dihydroxyvitamin D3 suppresses human T helper\/inducer lymphocyte activity in vitro","volume":"134","author":"Lemire","year":"1985","journal-title":"J Immunol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jdermsci.2007.12.003","article-title":"Vitamin D3 inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis","volume":"50","author":"Yamamoto","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0018","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jdv.12929","article-title":"Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid","volume":"30","author":"Tukaj","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0019","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2133.2012.10982.x","article-title":"Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases","volume":"167","author":"Marzano","year":"2012","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0230-0","article-title":"Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study","volume":"10","author":"Marzano","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1741-7015-11-171","article-title":"Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies","volume":"11","author":"Ramagopalan","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0022","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/bjd.12037","article-title":"Vitamin D status in patient with bullous pemphigoid","volume":"168","author":"Tukaj","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2016.02.004","article-title":"Association between bullous pemphigoid and hypovitaminosis D in older inpatients: results from a case-control study","volume":"31","author":"Sarre","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0024","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000359974","article-title":"Niacinamide: mechanisms of action and its topical use in dermatology","volume":"27","author":"Wohlrab","year":"2014","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0026","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0027","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1346-8138.2010.00920.x","article-title":"Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist","volume":"37","author":"Shiohara","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09546630050517649","article-title":"Treatment of generalized bullous pemphigoid with erythromycin and nicotinamide","volume":"11","author":"Florez","year":"2000","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid with tetracycline and niacinamide: a preliminary report","volume":"122","author":"Berk","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0030","first-page":"327","article-title":"Nicotinamide for the treatment of bullous pemphigold: our experience in Singapore","volume":"41","author":"Goon","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0190-9622(97)70336-0","article-title":"Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol","volume":"36","author":"Hornschuh","year":"1997","journal-title":"J Amer Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0032","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ijd.14270","article-title":"Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up","volume":"58","author":"Kalinska-Bienias","year":"2019","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0033","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0034","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0536.1993.tb03520.x","article-title":"Dyshidrosiform pemphigoid induced by nickel in the diet","volume":"29","author":"Atakan","year":"1993","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0036","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bjd.12228","article-title":"Bullous pemphigoid in an infant with milk protein allergy","volume":"169","author":"Cinotti","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0037","first-page":"36871","article-title":"Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept","author":"Kluk","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0038","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archderm.1992.01680210052006","article-title":"Serologic markers of gluten-sensitive enteropathy in bullous disease","volume":"128","author":"Kumar","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0039","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1468-3083.1998.tb00778.x","article-title":"Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous disease","volume":"11","author":"Economidou","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0040","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/eye.2012.119","article-title":"Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom","volume":"26","author":"Radford","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0041","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0042","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0043","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4103\/jisp.jisp_155_16","article-title":"Oral mucous membrane pemphigoid: two case reports with varied clinical presentation","volume":"20","author":"Dharman","year":"2016","journal-title":"J Indian Soc Periodontol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0044","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous membrane pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0045","first-page":"1","article-title":"Esophageal cicatricial pemphigoid as an isolated involvement treated with mycophenolate mofetil","author":"Sanchez","year":"2015","journal-title":"Case Rep Gastrointest Med"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0046","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/abd1806-4841.2019940207","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita \u2013 Brazilian Society of Dermatology","volume":"92","author":"Santi","year":"2019","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0047","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0738-081X(87)90047-2","article-title":"Cicatricial pemphigoid of upper digestive and respiratory tracts","volume":"5","author":"Bergstrom","year":"1987","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0048","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.autrev.2019.06.007","article-title":"Epidermolysis bullosa acquisita: a comprehensive review","volume":"18","author":"Kridin","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0049","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2340\/00015555-2110","article-title":"Childhood epidermolysis bullosa acquisita with underlying coeliac disease","volume":"95","author":"Kasperkiewicz","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0050","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.12278","article-title":"Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita","volume":"40","author":"Ito","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0051","first-page":"310","article-title":"Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment","volume":"33","author":"Hintner","year":"1982","journal-title":"Der Hautarzt"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0052","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.1976.tb00592.x","article-title":"Vitamin E treatment of epidermolysis bullosa acquisita","volume":"17","author":"Rosten","year":"1976","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0053","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1440-0960.1972.tb00513.x","article-title":"Therapeutic value of large doses of vitamin E in epidermolysis bullosa acquisita","volume":"13","author":"Ayres","year":"1972","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0054","first-page":"310","article-title":"Epidermolysis bullosa acquisita","volume":"56","author":"Nair","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1365-2133.1998.2576m.x","article-title":"Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin","volume":"139","author":"Harman","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0056","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ced.12114","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature","volume":"38","author":"Reddy","year":"2013","journal-title":"Clin Exp Dermaol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0057","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","article-title":"The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen","volume":"118","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0058","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0059","first-page":"576","article-title":"Micronutrient deficiencies in inflammatory bowel disease","volume":"18","author":"Weisshof","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/10408363.2014.992063","article-title":"Oxidized low-density lipoprotein as a biomarker of cardiovascular disease","volume":"52","author":"Trpkovic","year":"2015","journal-title":"Crtic Rev Clin Lab Sci."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0061","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jid.2017.09.009","article-title":"Calcitriol treatment ameliorates inflammation and blistering in mouse models of epidermolysis bullosa acquisita","volume":"138","author":"Tukaj","year":"2018","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0062","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.0901412","article-title":"T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita","volume":"184","author":"Sitaru","year":"2010","journal-title":"J Immunol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0063","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J Pathol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0064","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1111\/bjd.15995","article-title":"Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet","volume":"178","author":"Hietikko","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MPG.0000000000001420","article-title":"Extraintestinal manifestations of celiac disease: effectiveness of the gluten-free diet","volume":"65","author":"Jericho","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0066","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0067","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/ced.13992","article-title":"Dermatitis herpetiformis","volume":"44","author":"Salmi","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0068","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clindermatol.2011.03.010","article-title":"Dermatitis herpetiformis","volume":"30","author":"Karpati","year":"2012","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0069","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1523-1747.2000.00172.x","article-title":"Concordance of dermatitis herpetiformis and celiac disease in monozygous twins","volume":"115","author":"Hervonen","year":"2000","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00365521.2014.974204","article-title":"Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet","volume":"50","author":"Salmi","year":"2015","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0071","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/gut.2006.113084","article-title":"Latent coeliac disease or coeliac disease beyond villous atrophy?","volume":"56","author":"Kaukinen","year":"2007","journal-title":"Gut."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0072","first-page":"12","article-title":"Intestinal TG3- and TG2-specific plasma cell responses in dermatitis herpetiformis patients undergoing a gluten challenge","author":"Sankari","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0073","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000420022","article-title":"Role of elemental diet in dermatitis herpetiformis","volume":"20","author":"Van der Meer","year":"1991","journal-title":"Curr Probl Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0074","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.clindermatol.2010.03.036","article-title":"Nutrition and bullous skin diseases","volume":"28","author":"Fedeles","year":"2010","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0075","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/bjd.13387","article-title":"IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment","volume":"172","author":"Reunala","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0076","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555-2184","article-title":"Dermatitis herpetiformis refractory to gluten-free dietary treatment","volume":"96","author":"Hervonen","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0077","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archdermatol.2010.336","article-title":"Remission in dermatitis herpetiformis: a cohort study","volume":"147","author":"Paek","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0078","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.07086.x","article-title":"Complete resolution of dermatitis herpetiformis with the Atkins\u2019 diet","volume":"154","author":"Sladden","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0079","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archdermatol.2011.221","article-title":"Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin","volume":"147","author":"Antiga","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.43.4.490","article-title":"Tolerance to oats in dermatitis herpetiformis","volume":"43","author":"Reunala","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0081","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1056\/NEJM199805143382015","article-title":"Absence of toxicity of oats in patients with dermatitis herpetiformis","volume":"338","author":"Parnell","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0082","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.1974.tb15869.x","article-title":"Dermatitis herpetiformis: a case provoked by iodine","volume":"91","author":"From","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0083","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1980.tb07250.x","article-title":"The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone","volume":"103","author":"Haffenden","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0084","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archderm.1976.01630280073025","article-title":"Letter: iodide-induced immunofluorescence in dermatitis herpetiformis","volume":"112","author":"Charlesworth","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jdcr.2019.06.011","article-title":"Dermatitis herpetiformis resistant to dapsone due to dietary iodide ingestion","volume":"5","author":"Jimenez","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0086","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.jid.2018.03.1497","article-title":"Sensitivity of transglutaminase 3 in the IgA aggregates in dermatitis herpetiformis skin to potassium iodide","volume":"138","author":"Taylor","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0087","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2340\/0001555562211214","article-title":"Blood glutathione-peroxidase levels in skin diseases: effect of selenium and vitamin E treatment","volume":"62","author":"Juhlin","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0088","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2340\/0001555564546547","article-title":"Selenium, glutathione-peroxidase and dermatitis herpetiformis","volume":"64","author":"Ljunghall","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0089","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archderm.1992.01680120082007","article-title":"The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis","volume":"128","author":"Prussick","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0090","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archderm.1984.01650480044015","article-title":"Vitamin E and dapsone-induced hemolysis","volume":"120","author":"Kelly","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0091","first-page":"273","article-title":"Two cases of dermatitis herpetiformis successfully treated with tetracycline and niacinamide","volume":"26","author":"Wang","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0092","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0190-9622(08)81769-0","article-title":"Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone","volume":"28","author":"Zemtsov","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0093","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2230.2000.00615.x","article-title":"Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide","volume":"25","author":"Shah","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0094","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2004.08.033","article-title":"Flare of dermatitis herpetiformis associated with gluten in multivitamins","volume":"52","author":"Schalock","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0096","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1346-8138.2001.tb00056.x","article-title":"Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis","volume":"28","author":"Zone","year":"2001","journal-title":"J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0097","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00004836-198310000-00010","article-title":"Small-bowel involvement in dermatitis herpetiformis and in linear-IgA bullous dermatosis","volume":"5","author":"DeFranchis","year":"1983","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0098","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12514565","article-title":"Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits","volume":"74","author":"Lawley","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0099","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1572-0241.2001.03897.x","article-title":"Linear IgA bullous dermatosis responsive to a gluten-free diet","volume":"96","author":"Egan","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ced.12892","article-title":"Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide","volume":"41","author":"Cui","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0101","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1111\/ijd.12524","article-title":"A case of linear IgA dermatosis successfully treated with tetracycline and niacinamide","volume":"55","author":"Shan","year":"2016","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2133.1999.02996.x","article-title":"Sublamina densa-type linear IgA bullous dermatosis successfully treated with oral tetracycline and niacinamide","volume":"141","author":"Yomada","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0103","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0190-9622(08)80585-3","article-title":"Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide","volume":"26","author":"People","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0104","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0190-9622(08)80651-2","article-title":"Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases","volume":"28","author":"Chaffins","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2013.01.004","article-title":"Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.intimp.2016.04.031","article-title":"The dual nature of retinoic acid in pemphigus and its therapeutic potential: special focus on all-trans retinoic acid","volume":"36","author":"Tavakolpour","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0107","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.2005.01836.x","article-title":"Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease","volume":"30","author":"Rizzo","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0108","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1196\/annals.1443.017","article-title":"Retinoic acid in the immune system","volume":"1143","author":"Pino-Lagos","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0109","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1067\/mjd.2000.104002","article-title":"Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin","volume":"43","author":"Gruss","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10495-006-5115-1","article-title":"Programmed cell death of stressed keratinocytes and its inhibition by vitamin D: the role of death and survival signaling pathways","volume":"11","author":"Diker-Cohen","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0111","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jdv.12179","article-title":"Estimation of vitamin D levels in patients with pemphigus vulgaris","volume":"28","author":"El-Komy","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0112","first-page":"1544","article-title":"Evaluation of vitamin D status in newly diagnosed pemphigus vulgaris patients","volume":"43","author":"Zarei","year":"2014","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0113","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/1756-0500-7-536","article-title":"Vitamin D deficiency and lower TGF-B\/IL-17 ratio in a North Indian cohort of pemphigus vulgaris","volume":"7","author":"Joshi","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ced.12733","article-title":"Serum 25-hydroxy vitamin D level in patients with pemphigus and its association with disease severity","volume":"41","author":"Moravvej","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0115","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.oooo.2018.02.085","article-title":"Therapeutic success of vitamin D replacement in oral pemphigus vulgaris: a case report","volume":"126","author":"Arantes","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0116","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1529-8019.2002.01538.x","article-title":"Glucocorticoids in the treatment of bullous disease","volume":"15","author":"DeHoratius","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0117","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res (Hoboken"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jdv.13779","article-title":"Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide","volume":"31","author":"Von Kockrtiz","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.1995.tb08733.x","article-title":"Pemphigus vegetans with oesophageal involvement: successful treatment with minocycline and nicotinamide","volume":"132","author":"Sawai","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2014.04.040","article-title":"Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents","volume":"71","author":"McCarty","year":"2014","journal-title":"J Amer Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0121","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0738-081X(00)00154-1","article-title":"Autoimmune blistering diseases in children: signposts in the process of evaluation","volume":"18","author":"Brenner","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0122","first-page":"105","article-title":"Serum selenium, zinc, and copper in early diagnosed patients with pemphigus vulgaris","volume":"41","author":"Javanbakht","year":"2012","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0123","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-4632.2011.04968.x","article-title":"Serum zinc and copper status in Iranian patients with pemphigus vulgaris","volume":"50","author":"Yazdanpanah","year":"2011","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0124","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clindermatol.2011.01.016","article-title":"Drug-induced pemphigus","volume":"29","author":"Brenner","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0125","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/archderm.134.11.1406","article-title":"Diet and pemphigus: in pursuit of exogenous factors in pemphigus and fogo selvagem","volume":"134","author":"Tur","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0126","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000246684","article-title":"Pemphigus and dietary factors: in vitro acantholysis by allyl compounds of the genus Allium","volume":"190","author":"Brenner","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0127","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000246417","article-title":"A case of diet-related pemphigus","volume":"192","author":"Ruocco","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0128","first-page":"284","article-title":"Can pemphigus vulgaris be induced by nutritional factors?","volume":"6","author":"Chorzelski","year":"1996","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-4362.2001.01099.x","article-title":"Pemphigus and diet: does a link exist?","volume":"40","author":"Ruocco","year":"2001","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1747.2000.00056.x","article-title":"Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate","volume":"115","author":"Newby","year":"2000","journal-title":"J Invet Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alphs and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/039463200702000209","article-title":"Tannic acid induces in vitro acantholysis of keratinocytes via IL-1alpha and TNF-alpha","volume":"20","author":"Feliciani","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0133","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-4362.1997.00350.x","article-title":"The role of the water system as an exogenous factor in pemphigus","volume":"36","author":"Tur","year":"1997","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0134","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/eci.10.94","article-title":"A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris","volume":"7","author":"Caldarola","year":"2011","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0135","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1365-4362.2000.00938.x","article-title":"In vitro tannin acantholysis","volume":"39","author":"Brenner","year":"2000","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mehy.2011.09.041","article-title":"Chronic methyl mercury poisoning may trigger endemic pemphigus foliaceus \u201cfogo selvage","volume":"78","author":"Robledo","year":"2012","journal-title":"Med Hypotheses."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0137","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J Immunol."},{"key":"10.1016\/j.clindermatol.2021.10.009_bib0138","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2019.04.020","article-title":"Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a \u201chit-and-run\u201d mechanism","volume":"144","author":"Lin","year":"2019","journal-title":"J Allergy Clin Immunol."}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:45Z","timestamp":1760033985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0738081X21002212"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.10.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition and bullous diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}